200,000+ products from a single source!
sales@angenechem.com
1322-50-5 | 3-Pyridinecarboxamide, ar-(phenylmethyl)- (9CI)
CAS No: 1322-50-5 Catalog No: AG0010DA MDL No:
Product Description
Catalog Number:
AG0010DA
Chemical Name:
3-Pyridinecarboxamide, ar-(phenylmethyl)- (9CI)
CAS Number:
1322-50-5
Molecular Formula:
C13H12N2O
Molecular Weight:
212.2472
IUPAC Name:
N-benzylpyridine-3-carboxamide
InChI:
InChI=1S/C13H12N2O/c16-13(12-7-4-8-14-10-12)15-9-11-5-2-1-3-6-11/h1-8,10H,9H2,(H,15,16)
InChI Key:
JIAOUYONZMRJJD-UHFFFAOYSA-N
SMILES:
O=C(c1cccnc1)NCc1ccccc1
EC Number:
219-705-1
UNII:
HF1W0213QP
NSC Number:
59992
Properties
Complexity:
224
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
212.095g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
212.252g/mol
Monoisotopic Mass:
212.095g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
42A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5
Literature
| Title | Journal |
|---|---|
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Anticonvulsant and acute neurotoxic characteristics of nicotinic acid benzylamide: a preclinical study. | Pharmacological reports : PR 20060101 |
| Quinone reductase 2 substrate specificity and inhibition pharmacology. | Chemico-biological interactions 20050210 |
| Stability of two new anticonvulsants in body fluids and tissues. | Acta poloniae pharmaceutica 20040101 |
| Qualitative and quantitative analysis of three amino acid derivatives of anticonvulsant activity. | Acta poloniae pharmaceutica 20030101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.